448 related articles for article (PubMed ID: 12706085)
21. The avidity and lytic efficiency of the CTL response to HTLV-1.
Kattan T; MacNamara A; Rowan AG; Nose H; Mosley AJ; Tanaka Y; Taylor GP; Asquith B; Bangham CR
J Immunol; 2009 May; 182(9):5723-9. PubMed ID: 19380819
[TBL] [Abstract][Full Text] [Related]
22. Human T cell leukemia virus type I (HTLV-I) molecular genotypes and disease outcome.
Renjifo B; Chou K; Soto Ramirez L; Garcia Vallejo F; Essex M
J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S146-53. PubMed ID: 8797717
[TBL] [Abstract][Full Text] [Related]
23. Immunopathogenesis of HTLV-I-associated myelopathy/tropical spastic paraparesis.
Nakamura T
Ann Med; 2000 Dec; 32(9):600-7. PubMed ID: 11209967
[TBL] [Abstract][Full Text] [Related]
24. Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM/TSP).
Osame M
J Neurovirol; 2002 Oct; 8(5):359-64. PubMed ID: 12402162
[TBL] [Abstract][Full Text] [Related]
25. T cell receptor repertoire analysis in HTLV-1-associated diseases.
Clauze A; Enose-Akahata Y; Jacobson S
Front Immunol; 2022; 13():984274. PubMed ID: 36189294
[TBL] [Abstract][Full Text] [Related]
26. Human T-cell lymphotropic virus type-I (HTLV-I)-associated myelopathy/tropical spastic paraparesis with acute type of adult T-cell leukemia.
Furukawa Y; Okadome T; Tara M; Niina K; Izumo S; Osame M
Intern Med; 1995 Nov; 34(11):1130-3. PubMed ID: 8774979
[TBL] [Abstract][Full Text] [Related]
27. [Immunopathogenesis and treatment of the myelopathy associated to the HTLV-I virus].
Carod-Artal FJ
Rev Neurol; 2009 Feb 1-15; 48(3):147-55. PubMed ID: 19206063
[TBL] [Abstract][Full Text] [Related]
28. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma.
Giusti RM; Maloney EM; Hanchard B; Morgan OS; Steinberg SM; Wachter H; Williams E; Cranston B; Fuchs D; Manns A
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):699-704. PubMed ID: 8877061
[TBL] [Abstract][Full Text] [Related]
29. Immunopathogenesis of HTLV-I associated neurologic disease: massive latent HTLV-I infection in bone marrow of HAM/TSP patients.
Jacobson S; Krichavsky M; Flerlage N; Levin M
Leukemia; 1997 Apr; 11 Suppl 3():73-5. PubMed ID: 9209303
[TBL] [Abstract][Full Text] [Related]
30. Comparative virology of HTLV-1 and HTLV-2.
Martinez MP; Al-Saleem J; Green PL
Retrovirology; 2019 Aug; 16(1):21. PubMed ID: 31391116
[TBL] [Abstract][Full Text] [Related]
31. Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load.
Kubota R; Nagai M; Kawanishi T; Osame M; Jacobson S
AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1705-9. PubMed ID: 11080814
[TBL] [Abstract][Full Text] [Related]
32. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
[TBL] [Abstract][Full Text] [Related]
33. Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease.
Jacobson S
J Infect Dis; 2002 Dec; 186 Suppl 2():S187-92. PubMed ID: 12424696
[TBL] [Abstract][Full Text] [Related]
34. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.
Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; Taylor GP; Weber JN; Bangham CR
J Immunol; 2004 Feb; 172(3):1735-43. PubMed ID: 14734756
[TBL] [Abstract][Full Text] [Related]
35. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
[TBL] [Abstract][Full Text] [Related]
36. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
[TBL] [Abstract][Full Text] [Related]
37. Role of the HTLV-1 viral factors in the induction of apoptosis.
Karimi M; Mohammadi H; Hemmatzadeh M; Mohammadi A; Rafatpanah H; Baradaran B
Biomed Pharmacother; 2017 Jan; 85():334-347. PubMed ID: 27887847
[TBL] [Abstract][Full Text] [Related]
38. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.
Ureta-Vidal A; Pique C; Garcia Z; Dehée A; Tortevoye P; Désiré N; Gessain A; Chancerel B; Gout O; Lemonnier FA; Cochet M
J Infect Dis; 2001 Mar; 183(6):857-64. PubMed ID: 11237801
[TBL] [Abstract][Full Text] [Related]
39. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
[TBL] [Abstract][Full Text] [Related]
40. Human T-cell lymphotropic virus type I and neurological diseases.
Nagai M; Osame M
J Neurovirol; 2003 Apr; 9(2):228-35. PubMed ID: 12707853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]